(+)-dexrazoxane multiple interactions ISO RGD:1319821 6480464 Dexrazoxane inhibits the reaction [Idarubicin results in decreased expression of EXO1 mRNA], Dexrazoxane inhibits the reaction [Idarubicin results in decreased expression of EXO1 protein] CTD PMID:28973540 (-)-demecolcine decreases expression ISO RGD:1319820 6480464 Demecolcine results in decreased expression of EXO1 mRNA CTD PMID:23649840 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of EXO1 mRNA CTD PMID:30723492 17beta-estradiol increases expression ISO RGD:1319820 6480464 Estradiol results in increased expression of EXO1 mRNA CTD PMID:19167446 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1319821 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1319821 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1319821 6480464 [Tetrachlorodibenzodioxin co-treated with AHR gene mutant form] results in decreased expression of EXO1 mRNA CTD PMID:19465110 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1319820 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in increased expression of EXO1 mRNA CTD PMID:26159488 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1319821 6480464 Tetrachlorodibenzodioxin affects the expression of EXO1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1319820 6480464 Tetrachlorodibenzodioxin results in decreased expression of EXO1 mRNA CTD PMID:21802500 2,4-diaminotoluene increases expression ISO RGD:1319821 6480464 2, 4-diaminotoluene results in increased expression of EXO1 mRNA CTD PMID:20713471 2-methylcholine affects expression ISO RGD:1319820 6480464 beta-methylcholine affects the expression of EXO1 mRNA CTD PMID:21179406 3-methylcholanthrene increases expression ISO RGD:1319821 6480464 Methylcholanthrene results in increased expression of EXO1 mRNA CTD PMID:20713471 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1319821 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of EXO1 promoter CTD PMID:33297965 5-fluorouracil affects response to substance ISO RGD:1319820 6480464 HEXO1 protein affects the susceptibility to Fluorouracil CTD PMID:16477629 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of EXO1 mRNA CTD PMID:24780913 acetamide increases expression EXP 6480464 acetamide results in increased expression of EXO1 mRNA CTD PMID:31881176 acrolein multiple interactions ISO RGD:1319820 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of EXO1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of EXO1 mRNA CTD PMID:32699268 acrylamide decreases expression ISO RGD:1319820 6480464 Acrylamide results in decreased expression of EXO1 mRNA CTD PMID:32763439 aflatoxin B1 affects expression ISO RGD:1319820 6480464 Aflatoxin B1 affects the expression of EXO1 protein CTD PMID:20106945 aflatoxin B1 increases expression ISO RGD:1319820 6480464 Aflatoxin B1 results in increased expression of EXO1 mRNA CTD PMID:22100608 all-trans-retinoic acid decreases expression ISO RGD:1319820 6480464 Tretinoin results in decreased expression of EXO1 mRNA CTD PMID:33167477 alpha-pinene multiple interactions ISO RGD:1319820 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of EXO1 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of EXO1 mRNA CTD PMID:32699268 amiodarone increases expression ISO RGD:1319820 6480464 Amiodarone results in increased expression of EXO1 mRNA CTD PMID:19774075 atrazine decreases expression ISO RGD:1319820 6480464 Atrazine results in decreased expression of EXO1 mRNA CTD PMID:22378314 azathioprine decreases expression ISO RGD:1319820 6480464 Azathioprine results in decreased expression of EXO1 mRNA CTD PMID:22623647 barium sulfate affects expression EXP 6480464 Barium Sulfate affects the expression of EXO1 mRNA CTD PMID:29463257 belinostat decreases expression ISO RGD:1319821 6480464 belinostat results in decreased expression of EXO1 protein CTD PMID:29733868 benzalkonium chloride increases expression ISO RGD:1319821 6480464 Benzalkonium Compounds results in increased expression of EXO1 mRNA CTD PMID:30171875 benzo[a]pyrene increases expression ISO RGD:1319821 6480464 Benzo(a)pyrene results in increased expression of EXO1 mRNA CTD PMID:20713471 benzo[a]pyrene decreases methylation ISO RGD:1319820 6480464 Benzo(a)pyrene results in decreased methylation of EXO1 promoter CTD PMID:27901495 benzo[a]pyrene decreases methylation ISO RGD:1319821 6480464 Benzo(a)pyrene results in decreased methylation of EXO1 exon, Benzo(a)pyrene results in decreased methylation of EXO1 intron CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1319820 6480464 Benzo(a)pyrene results in increased expression of EXO1 mRNA CTD PMID:22316170 more ... benzo[a]pyrene decreases expression ISO RGD:1319820 6480464 Benzo(a)pyrene results in decreased expression of EXO1 mRNA CTD PMID:20064835 , PMID:21802500 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1319820 6480464 7 more ... CTD PMID:20382639 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1319820 6480464 7 more ... CTD PMID:26238291 benzo[b]fluoranthene increases expression ISO RGD:1319821 6480464 benzo(b)fluoranthene results in increased expression of EXO1 mRNA CTD PMID:26377693 biphenyl-4-amine decreases expression ISO RGD:1319820 6480464 4-biphenylamine results in decreased expression of EXO1 mRNA CTD PMID:24857880 bis(2-chloroethyl) sulfide increases expression ISO RGD:1319820 6480464 Mustard Gas results in increased expression of EXO1 mRNA CTD PMID:33491125 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of EXO1 mRNA CTD PMID:25181051 bisphenol A multiple interactions ISO RGD:1319820 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of EXO1 gene CTD PMID:31601247 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with tributyltin] results in increased expression of EXO1 mRNA CTD PMID:31129395 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of EXO1 mRNA CTD PMID:30816183 , PMID:32528016 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of EXO1 mRNA CTD PMID:31077537 cadmium dichloride multiple interactions EXP 6480464 [Cadmium Chloride co-treated with diallyl disulfide] results in increased expression of EXO1 mRNA CTD PMID:31077537 calcitriol decreases expression ISO RGD:1319820 6480464 Calcitriol results in decreased expression of EXO1 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:1319820 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of EXO1 mRNA CTD PMID:21592394 cannabidiol decreases expression ISO RGD:1319820 6480464 Cannabidiol results in decreased expression of EXO1 mRNA CTD PMID:36519830 carbon nanotube increases expression ISO RGD:1319821 6480464 Nanotubes more ... CTD PMID:25554681 cefaloridine increases expression EXP 6480464 Cephaloridine results in increased expression of EXO1 mRNA CTD PMID:18500788 ceric oxide affects expression EXP 6480464 ceric oxide affects the expression of EXO1 mRNA CTD PMID:29463257 choline multiple interactions ISO RGD:1319821 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EXO1 mRNA CTD PMID:20938992 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of EXO1 mRNA CTD PMID:22023808 cisplatin increases expression ISO RGD:1319820 6480464 Cisplatin results in increased expression of EXO1 mRNA CTD PMID:27594783 cobalt dichloride decreases expression ISO RGD:1319820 6480464 cobaltous chloride results in decreased expression of EXO1 mRNA CTD PMID:19320972 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of EXO1 mRNA CTD PMID:24386269 copper atom multiple interactions ISO RGD:1319820 6480464 [NSC 689534 binds to Copper] which results in decreased expression of EXO1 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:1319820 6480464 [NSC 689534 binds to Copper] which results in decreased expression of EXO1 mRNA CTD PMID:20971185 copper(II) sulfate decreases expression ISO RGD:1319820 6480464 Copper Sulfate results in decreased expression of EXO1 mRNA CTD PMID:19549813 coumarin affects phosphorylation ISO RGD:1319820 6480464 coumarin affects the phosphorylation of EXO1 protein CTD PMID:35688186 coumestrol increases expression ISO RGD:1319820 6480464 Coumestrol results in increased expression of EXO1 mRNA CTD PMID:19167446 coumestrol multiple interactions ISO RGD:1319820 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 cyclosporin A decreases expression ISO RGD:1319820 6480464 Cyclosporine results in decreased expression of EXO1 mRNA CTD PMID:19159671 more ... desferrioxamine B multiple interactions ISO RGD:1319820 6480464 [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of EXO1 mRNA more ... CTD PMID:35690295 diallyl disulfide increases expression EXP 6480464 diallyl disulfide results in increased expression of EXO1 mRNA CTD PMID:31077537 diallyl disulfide multiple interactions EXP 6480464 [Cadmium Chloride co-treated with diallyl disulfide] results in increased expression of EXO1 mRNA CTD PMID:31077537 dibutyl phthalate decreases expression ISO RGD:1319821 6480464 Dibutyl Phthalate results in decreased expression of EXO1 mRNA CTD PMID:17361019 , PMID:21266533 diethyl maleate increases expression EXP 6480464 diethyl maleate results in increased expression of EXO1 mRNA CTD PMID:21161181 dioxygen decreases expression ISO RGD:1319820 6480464 Oxygen deficiency results in decreased expression of EXO1 mRNA CTD PMID:26516004 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of EXO1 mRNA CTD PMID:27181935 doxorubicin multiple interactions EXP 6480464 Fungal Polysaccharides inhibits the reaction [Doxorubicin results in decreased expression of EXO1 mRNA] CTD PMID:27181935 endosulfan multiple interactions ISO RGD:1319820 6480464 [Endosulfan co-treated with Tetrachlorodibenzodioxin] results in increased expression of EXO1 mRNA CTD PMID:26159488 Enterolactone multiple interactions ISO RGD:1319820 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of EXO1 mRNA CTD PMID:19167446 ethyl methanesulfonate increases expression ISO RGD:1319820 6480464 Ethyl Methanesulfonate results in increased expression of EXO1 mRNA CTD PMID:23649840 flumequine multiple interactions ISO RGD:1319821 6480464 [flumequine co-treated with 2-amino-3 more ... CTD PMID:23681119 folic acid multiple interactions ISO RGD:1319821 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EXO1 mRNA CTD PMID:20938992 fulvestrant multiple interactions ISO RGD:1319820 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of EXO1 gene CTD PMID:31601247 furan increases expression EXP 6480464 furan results in increased expression of EXO1 mRNA CTD PMID:22079235 , PMID:22507866 glyphosate decreases expression ISO RGD:1319820 6480464 glyphosate results in decreased expression of EXO1 mRNA CTD PMID:31295307 idarubicin multiple interactions ISO RGD:1319821 6480464 Dexrazoxane inhibits the reaction [Idarubicin results in decreased expression of EXO1 mRNA], Dexrazoxane inhibits the reaction [Idarubicin results in decreased expression of EXO1 protein] CTD PMID:28973540 idarubicin decreases expression ISO RGD:1319821 6480464 Idarubicin results in decreased expression of EXO1 mRNA, Idarubicin results in decreased expression of EXO1 protein CTD PMID:28973540 kenpaullone decreases expression EXP 6480464 kenpaullone results in decreased expression of EXO1 mRNA CTD PMID:17993264 L-methionine multiple interactions ISO RGD:1319821 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EXO1 mRNA CTD PMID:20938992 Lasiocarpine increases expression ISO RGD:1319820 6480464 lasiocarpine results in increased expression of EXO1 mRNA CTD PMID:32234424 lead(0) affects expression ISO RGD:1319820 6480464 Lead affects the expression of EXO1 mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:1319820 6480464 Lead affects the expression of EXO1 mRNA CTD PMID:28903495 lucanthone decreases expression ISO RGD:1319820 6480464 Lucanthone results in decreased expression of EXO1 mRNA CTD PMID:21148553 MeIQx multiple interactions ISO RGD:1319821 6480464 [flumequine co-treated with 2-amino-3 more ... CTD PMID:23681119 methyl methanesulfonate increases expression ISO RGD:1319820 6480464 Methyl Methanesulfonate results in increased expression of EXO1 mRNA CTD PMID:23649840 miconazole increases expression ISO RGD:1319821 6480464 Miconazole results in increased expression of EXO1 mRNA CTD PMID:27462272 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of EXO1 mRNA CTD PMID:23358140 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of EXO1 mRNA CTD PMID:25729387 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of EXO1 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1319820 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of EXO1 mRNA more ... CTD PMID:32699268 ozone multiple interactions ISO RGD:1319821 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of EXO1 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in increased expression of EXO1 mRNA CTD PMID:34911549 palbociclib decreases expression ISO RGD:1319820 6480464 palbociclib results in decreased expression of EXO1 mRNA CTD PMID:22869556 paracetamol increases expression ISO RGD:1319820 6480464 Acetaminophen results in increased expression of EXO1 mRNA CTD PMID:22230336 PCB138 multiple interactions ISO RGD:1319821 6480464 [2 more ... CTD PMID:25510870 perfluorooctane-1-sulfonic acid increases expression ISO RGD:1319820 6480464 perfluorooctane sulfonic acid results in increased expression of EXO1 mRNA CTD PMID:27153767 perfluorooctanoic acid decreases expression ISO RGD:1319820 6480464 perfluorooctanoic acid results in decreased expression of EXO1 mRNA CTD PMID:36326898 phenobarbital affects expression ISO RGD:1319820 6480464 Phenobarbital affects the expression of EXO1 mRNA CTD PMID:19159669 phenobarbital increases expression ISO RGD:1319821 6480464 Phenobarbital results in increased expression of EXO1 mRNA CTD PMID:23091169 phosphoramide mustard increases expression EXP 6480464 phosphoramide mustard results in increased expression of EXO1 mRNA CTD PMID:26708502 picoxystrobin increases expression ISO RGD:1319820 6480464 picoxystrobin results in increased expression of EXO1 mRNA CTD PMID:33512557 pirinixic acid increases expression ISO RGD:1319821 6480464 pirinixic acid results in increased expression of EXO1 mRNA CTD PMID:18301758 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:1319821 6480464 Pregnenolone Carbonitrile results in increased expression of EXO1 mRNA CTD PMID:22698814 progesterone decreases expression ISO RGD:1319821 6480464 Progesterone results in decreased expression of EXO1 mRNA CTD PMID:22238285 resveratrol multiple interactions ISO RGD:1319820 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of EXO1 mRNA CTD PMID:19167446 resveratrol decreases expression EXP 6480464 Resveratrol results in decreased expression of EXO1 mRNA CTD PMID:33775663 rotenone increases expression ISO RGD:1319820 6480464 Rotenone results in increased expression of EXO1 mRNA CTD PMID:18191903 rotenone decreases expression ISO RGD:1319820 6480464 Rotenone results in decreased expression of EXO1 mRNA CTD PMID:33512557 silicon dioxide decreases expression ISO RGD:1319820 6480464 Silicon Dioxide analog results in decreased expression of EXO1 mRNA CTD PMID:23806026 sodium arsenite affects expression ISO RGD:1319820 6480464 sodium arsenite affects the expression of EXO1 mRNA CTD PMID:29301061 sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of EXO1 mRNA CTD PMID:22110744 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of EXO1 mRNA CTD PMID:22561333 sodium dichromate increases expression ISO RGD:1319821 6480464 sodium bichromate results in increased expression of EXO1 mRNA CTD PMID:22155349 succimer multiple interactions ISO RGD:1319821 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of EXO1 mRNA, [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of EXO1 mRNA CTD PMID:21641980 , PMID:26378955 tebufenpyrad increases expression ISO RGD:1319820 6480464 4-chloro-N-((4-(1, 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of EXO1 mRNA CTD PMID:33512557 tert-butyl hydroperoxide multiple interactions ISO RGD:1319820 6480464 [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of EXO1 mRNA more ... CTD PMID:35690295 testosterone multiple interactions ISO RGD:1319820 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of EXO1 mRNA CTD PMID:21592394 testosterone increases expression ISO RGD:1319820 6480464 Testosterone results in increased expression of EXO1 mRNA CTD PMID:33359661 testosterone decreases expression ISO RGD:1319820 6480464 Testosterone results in decreased expression of EXO1 mRNA CTD PMID:21592394 tetrachloromethane increases expression ISO RGD:1319821 6480464 Carbon Tetrachloride results in increased expression of EXO1 mRNA CTD PMID:17484886 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of EXO1 mRNA CTD PMID:30723492 thapsigargin decreases expression ISO RGD:1319820 6480464 Thapsigargin results in decreased expression of EXO1 mRNA CTD PMID:22378314 titanium dioxide increases expression ISO RGD:1319821 6480464 titanium dioxide results in increased expression of EXO1 mRNA CTD PMID:23557971 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of EXO1 mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of EXO1 mRNA CTD PMID:25729387 tributylstannane multiple interactions EXP 6480464 [bisphenol A co-treated with tributyltin] results in increased expression of EXO1 mRNA CTD PMID:31129395 triclosan decreases expression ISO RGD:1319820 6480464 Triclosan results in decreased expression of EXO1 mRNA CTD PMID:30510588 trimellitic anhydride increases expression ISO RGD:1319821 6480464 trimellitic anhydride results in increased expression of EXO1 mRNA CTD PMID:19042947 troglitazone decreases expression ISO RGD:1319820 6480464 troglitazone results in decreased expression of EXO1 mRNA CTD PMID:19140230 valproic acid decreases expression ISO RGD:1319821 6480464 Valproic Acid results in decreased expression of EXO1 mRNA CTD PMID:21427059 valproic acid affects expression ISO RGD:1319820 6480464 Valproic Acid affects the expression of EXO1 mRNA CTD PMID:25979313 vincristine decreases expression ISO RGD:1319820 6480464 Vincristine results in decreased expression of EXO1 mRNA CTD PMID:23649840
